No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RSKD240517P5000
- 0.27
- +0.07+35.00%
15min DelayClose May 10 15:57 ET
0.27High0.27Low
0.27Open0.20Pre Close1 Volume18 Open Interest5.00Strike Price27.00Turnover113.69%IV-8.17%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.27Time Value100Contract SizeAmericanOptions Type-0.3687Delta0.4651Gamma23.11Leverage Ratio-0.0228Theta-0.0004Rho-8.52Eff Leverage0.0027Vega
Intraday
- 5D
- 1D
News
Riskified to Present at Upcoming Conferences
Riskified Ltd. (NYSE: RSKD), a leader in eCommerce fraud and risk intelligence, today announced that management will present and host investor meetings at the following upcoming conferences:
Riskified Price Target Maintained With a $7.00/Share by Piper Sandler
Riskified Price Target Maintained With a $7.00/Share by Piper Sandler
Piper Sandler Reiterates Overweight on Riskified, Maintains $7 Price Target
Piper Sandler analyst Clarke Jeffries reiterates Riskified (NYSE:RSKD) with a Overweight and maintains $7 price target.
Riskified Ltd. Continues $75M Share Buyback
Where Riskified Stands With Analysts
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Riskified (NYSE:RSKD) in the last three months.Summarizing their recent assessments, the table b
Riskified Initiated at Market Perform by Keefe, Bruyette & Woods
Riskified Initiated at Market Perform by Keefe, Bruyette & Woods
Comments
Riskified's decreasing cash burn and rising revenues hint a solid growth trajectory. Various factors making its cash burn situation seem safer include cash runway, revenue growth and ability to secure additional capital.
Companies Like Riskified (NYSE:RSKD) Can Afford To Invest In Growth
Gainers:
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US$+17%, $Workiva(WK.US$ +15.3%, $Arlo Technologies(ARLO.US$ +12%, $Array Technologies(ARRY.US$ +10.3%, $Everbridge(EVBG.US$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US$ +9.4%, $Halozyme Therapeutics(HALO.US$ +8.7%, $Velo3D(VLD.US$ +7.6%, $CyberArk(CYBR.US$ + 6.2%, $Haemonetics(HAE.US$ +5.8%, $Jackson Financial(JXN.US$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US$ +4.8%,...
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US$+17%, $Workiva(WK.US$ +15.3%, $Arlo Technologies(ARLO.US$ +12%, $Array Technologies(ARRY.US$ +10.3%, $Everbridge(EVBG.US$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US$ +9.4%, $Halozyme Therapeutics(HALO.US$ +8.7%, $Velo3D(VLD.US$ +7.6%, $CyberArk(CYBR.US$ + 6.2%, $Haemonetics(HAE.US$ +5.8%, $Jackson Financial(JXN.US$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US$ +4.8%,...
11
2
CAN I AT LEAST LEARN HOW TO BUY N SELL STOCKS ON THIS Brokerage MOOMOO. 
FOR REAL I DONT GET IT 
$Riskified(RSKD.US$ all in, let’s go
2
2
Read more